Core outcome measurement set for clinical trials in dengue: an international Delphi consensus study (DEN-CORE).
Yacoub S, Demidova A, Chan XHS, Ajam A, Baimukhambetova D, Horn A, Kakotkina E, Kosenko M, Mursalova A, Van Nuil JI, Phuong CL, Xiao L, Adhikari S, Alzate Alvarez JD, Anderson KB, Avirutnan P, Buchholz S, Chandra R, Chang AY, Quang Chanh H, Consuegra Rodríguez MP, Daniel V, Diaz JV, Figueiredo-Mello C, Gelvez-Ramírez RM, Huyen TB, Kestelyn E, Lam PK, Leopold SJ, Li R, Luu T, Lye DCB, McBride A, Meyer-Andrieux I, Moorman NJ, Nguyen NM, Omar SFS, Ong HC, Ooi EE, Pazukhina E, Pett SL, Porto DB, Rajahram GS, Rogers M, Rojas E, Rosen J, Rylance J, Schilling WHK, Siqueira AM, Sjö P, Sucerquia-Hernandez A, Tam DTH, Teixeira MM, Tietz A, Trieu HT, Unsworth A, Villar L, Waickman AT, Watson JA, Wills BA, Chia PY, Brasil P, Jaenisch T, Lum L, Malavige GN, McGloughlin S, Tirupakuzhi Vijayaraghavan BK, Merson L, Munblit D; DEN-CORE Study Group.
Yacoub S, et al.
Lancet Infect Dis. 2026 Apr;26(4):e231-e244. doi: 10.1016/S1473-3099(25)00500-6. Epub 2025 Oct 7.
Lancet Infect Dis. 2026.
PMID: 41072450
Review.